Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1030 | 1036 | 879 | 622 | 1715 | - |
Fund Return | 3.02% | 3.63% | -12.06% | -14.65% | 11.4% | - |
Place in category | 1 | 12 | 18 | 19 | 5 | - |
% in Category | 1 | 6 | 8 | 15 | 9 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Changsheng Tongde Thematic Growth F | 706.9M | 5.21 | -8.30 | 7.86 | ||
ChangSheng Electronic Infor Ser St | 629.96M | -9.02 | -18.52 | 2.99 | ||
ChangSheng Tongsheng Gr Sel All LOF | 622.58M | -1.58 | -9.52 | - | ||
Changsheng Quantification Of Divide | 460.33M | 14.22 | 4.88 | 17.32 | ||
Changsheng Stated Owned Reform mix | 336.81M | 2.94 | -21.00 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ICBCCS QY Medical Eq | 12.74B | -8.25 | -16.47 | - | ||
CMF CNI Bio Health Index | 10.36B | -22.51 | -30.05 | - | ||
GF YiLiao BaoJian Eq A | 6.97B | -8.17 | -24.93 | - | ||
Hwabao WP CSI Medical Index | 5.97B | -16.18 | -27.42 | - | ||
Penghua Medical Tech Eq | 3.78B | -12.06 | -10.59 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shenzhen Mindray Bio-Medical | CNE100003G67 | 4.92 | 285.79 | +0.63% | |
Beijing Tongrentang | CNE000000R69 | 4.09 | 38.53 | +1.24% | |
Dong-E E-Jiao A | CNE0000006Y9 | 3.66 | 62.78 | +3.77% | |
Yiling Pharma A | CNE1000015S0 | 3.61 | 15.32 | +3.65% | |
Renhe Pharm A | CNE000000NF8 | 3.39 | 6.05 | +1.85% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review